Jin-hua X. Wang
Key Laboratory Of Drug Target Research And Drug Screen, Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
GD3s-mediated lipid metabolism reprograming promotes proliferation and metastasis of melanoma.
Journal: Journal of translational medicine
Published: December 21, 2025
METTL7A inhibits progression of colorectal cancer through the SREBP1 / FDFT1 / SQLE / CYP51A1 / cholesterol metabolic pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 04, 2025
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
Journal: Clinical epigenetics
Published: December 28, 2024
3-O-Acetyl-11-Keto-β-Boswellic Acid Suppresses Colitis-Associated Colorectal Cancer by Inhibiting the NF-Kb Signaling Pathway and Remodeling Gut Microbiota.
Journal: Oncology research
Published: December 17, 2024
Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway.
Journal: Cancer cell international
Published: August 03, 2024
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 29, 2024
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Journal: Signal transduction and targeted therapy
Published: July 13, 2024
Author Correction: ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway.
Journal: Acta pharmacologica Sinica
Published: June 25, 2024
Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
Journal: Acta pharmacologica Sinica
Published: May 13, 2024
Progress of studies on natural products for glioblastoma therapy.
Journal: Journal of Asian natural products research
Published: February 07, 2024
AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway.
Journal: Cancer cell international
Published: November 10, 2023
S670, an amide derivative of 3-O-acetyl-11-keto-β-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome.
Journal: Acta pharmacologica Sinica
Published: May 28, 2023
Last Updated: 09/26/2026